Lucia Lassiani

439 total citations
42 papers, 339 citations indexed

About

Lucia Lassiani is a scholar working on Organic Chemistry, Molecular Biology and Physical and Theoretical Chemistry. According to data from OpenAlex, Lucia Lassiani has authored 42 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 20 papers in Molecular Biology and 10 papers in Physical and Theoretical Chemistry. Recurrent topics in Lucia Lassiani's work include Chemical Reactions and Mechanisms (9 papers), Neuropeptides and Animal Physiology (7 papers) and Receptor Mechanisms and Signaling (7 papers). Lucia Lassiani is often cited by papers focused on Chemical Reactions and Mechanisms (9 papers), Neuropeptides and Animal Physiology (7 papers) and Receptor Mechanisms and Signaling (7 papers). Lucia Lassiani collaborates with scholars based in Italy, Greece and Slovenia. Lucia Lassiani's co-authors include Gianni Sava, Tullio Giraldi, Giancarlo Verardo, Angelo G. Giumanini, Laura Mennuni, Ennio Zangrando, Francesco Makovec, Federico Berti, L. Perissin and Miranda L. Perry and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Lucia Lassiani

41 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucia Lassiani Italy 11 154 139 71 39 33 42 339
Tom R. Dean United States 7 142 0.9× 236 1.7× 45 0.6× 15 0.4× 18 0.5× 7 409
Joseph D. Schroeder United States 12 310 2.0× 141 1.0× 50 0.7× 68 1.7× 14 0.4× 15 538
W. Keller Germany 13 216 1.4× 88 0.6× 62 0.9× 26 0.7× 12 0.4× 44 453
William J. Welstead United States 13 347 2.3× 120 0.9× 27 0.4× 20 0.5× 24 0.7× 29 492
Noel A. Powell United States 17 459 3.0× 309 2.2× 27 0.4× 25 0.6× 22 0.7× 29 751
T Takino Japan 11 378 2.5× 119 0.9× 37 0.5× 26 0.7× 18 0.5× 16 596
Tomonaga Ozawa Japan 16 168 1.1× 275 2.0× 64 0.9× 32 0.8× 30 0.9× 22 527
Philippe Piéchon Switzerland 11 73 0.5× 163 1.2× 58 0.8× 110 2.8× 15 0.5× 14 347
Jakov Ivković Austria 8 88 0.6× 133 1.0× 59 0.8× 52 1.3× 14 0.4× 8 347
Allan Hallett United Kingdom 12 227 1.5× 405 2.9× 14 0.2× 41 1.1× 64 1.9× 17 621

Countries citing papers authored by Lucia Lassiani

Since Specialization
Citations

This map shows the geographic impact of Lucia Lassiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Lassiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Lassiani more than expected).

Fields of papers citing papers by Lucia Lassiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucia Lassiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Lassiani. The network helps show where Lucia Lassiani may publish in the future.

Co-authorship network of co-authors of Lucia Lassiani

This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Lassiani. A scholar is included among the top collaborators of Lucia Lassiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Lassiani. Lucia Lassiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perry, Miranda L., Matteo Lusi, Michele R. Chierotti, et al.. (2016). Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization. Journal of Pharmaceutical Sciences. 105(12). 3626–3633. 36 indexed citations
2.
Lassiani, Lucia, Federico Berti, G. STEFANCICH, et al.. (2011). New Anthranilic Acid Based Antagonists with High Affinity and Selectivity for the Human Cholecystokinin Receptor 1 (hCCK1-R). Journal of Medicinal Chemistry. 54(16). 5769–5785. 4 indexed citations
3.
Hadjipavlou‐Litina, Dimitra, et al.. (2009). 2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK1 receptor antagonists: ‘Hic Rhodus, hic saltus’. Bioorganic & Medicinal Chemistry. 17(14). 5198–5206. 2 indexed citations
4.
Lassiani, Lucia, et al.. (2009). Anthranilic acid based CCK1 receptor antagonists: Blocking the receptor with the same ‘words’ of the endogenous ligand. Bioorganic & Medicinal Chemistry. 17(6). 2336–2350. 12 indexed citations
5.
Lassiani, Lucia, et al.. (2006). Twenty years of non-peptide CCK1receptor antagonists: all that glitters is not gold. Expert Opinion on Therapeutic Patents. 16(9). 1193–1213. 8 indexed citations
6.
Luca, Stefania De, Michele Saviano, Lucia Lassiani, et al.. (2006). Anthranilic Acid Based CCK1 Receptor Antagonists and CCK-8 Have a Common Step in Their “Receptor Desmodynamic Processes”. Journal of Medicinal Chemistry. 49(8). 2456–2462. 9 indexed citations
7.
Lassiani, Lucia, et al.. (2005). Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second “touch point”. European Journal of Medicinal Chemistry. 40(6). 563–581. 12 indexed citations
8.
Lassiani, Lucia, et al.. (2004). Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a “needle” according to the recent homonymous concept. European Journal of Medicinal Chemistry. 39(1). 85–97. 13 indexed citations
9.
Lassiani, Lucia, et al.. (2003). Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists. Bioorganic & Medicinal Chemistry. 11(5). 741–751. 19 indexed citations
10.
Berti, Federico, et al.. (2001). Synthesis of N-terminal substituted anthranilic acid dimer derivatives for evaluation on CCK receptors. Il Farmaco. 56(8). 555–564. 3 indexed citations
11.
Lassiani, Lucia, et al.. (2000). Synthesis of new anthranilic acid dimer derivatives and their evaluation on CCK receptors. Il Farmaco. 55(5). 369–375. 4 indexed citations
12.
Lassiani, Lucia, et al.. (2000). C-terminal anthranoyl–anthranilic acid derivatives and their evaluation on CCK receptors. Il Farmaco. 55(4). 293–302. 7 indexed citations
13.
Zacchigna, Marina, et al.. (1999). Improved Activity in Acidic Media of Immobilized Lysozyme. Applied Biochemistry and Biotechnology. 76(3). 171–182. 6 indexed citations
14.
Lassiani, Lucia, et al.. (1996). Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors.. PubMed. 51(5). 333–50. 2 indexed citations
15.
16.
Sava, Gianni, Sonia Zorzet, L. Perissin, Tullio Giraldi, & Lucia Lassiani. (1988). Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes. Cancer Chemotherapy and Pharmacology. 21(3). 241–5. 2 indexed citations
17.
Sava, Gianni, L. Perissin, Lucia Lassiani, & Giuliano Zabucchi. (1985). Antiinflammatory action of hydrosoluble dimethyl-triazenes on the carrageenin-induced edema in guinea pigs. Chemico-Biological Interactions. 53(1-2). 37–43. 15 indexed citations
18.
Sava, Gianni, et al.. (1985). Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.. PubMed. 7(9). 477–80. 1 indexed citations
19.
Giraldi, Tullio, et al.. (1981). Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.. PubMed. 41(6). 2524–8. 35 indexed citations
20.
Lassiani, Lucia, et al.. (1980). Synthesis of l-Aryl-3-formyl-3-methyltriazenes, Potential Metabolites of l-Ary1-3,3-dimethyltriazenes. Journal of Pharmaceutical Sciences. 69(9). 1098–1099. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tom R. Dean Breakdown of academic impact, for papers by Joseph D. Schroeder Breakdown of academic impact, for papers by W. Keller Breakdown of academic impact, for papers by William J. Welstead Breakdown of academic impact, for papers by Noel A. Powell Breakdown of academic impact, for papers by T Takino Breakdown of academic impact, for papers by Tomonaga Ozawa Breakdown of academic impact, for papers by Philippe Piéchon Breakdown of academic impact, for papers by Jakov Ivković Breakdown of academic impact, for papers by Allan Hallett
Rankless by CCL
2026